MEIRAGTX HLDGSDL-,0000388 revenue breakdown overview

MEIRAGTX HLDGSDL-,0000388 revenue for the last year amounted to 12.70 M EUR, the most of which — 12.70 M EUR — came from its highest performing source at the moment, Retinal Drugs and Gene Therapies, the year earlier bringing 14.88 M EUR. The greatest contribution to the revenue figure was made by United Kingdom — last year it brought MEIRAGTX HLDGSDL-,0000388 12.70 M EUR, and the year before that — 14.88 M EUR.